Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $13,341 | 615 | 98.9% |
| Education | $84.62 | 9 | 0.6% |
| Debt forgiveness | $61.00 | 1 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,246 | 36 | $0 (2024) |
| Novo Nordisk Inc | $1,205 | 84 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,098 | 38 | $0 (2024) |
| Lilly USA, LLC | $852.68 | 42 | $0 (2024) |
| Merz North America, Inc. | $685.42 | 10 | $0 (2022) |
| GlaxoSmithKline, LLC. | $681.33 | 53 | $0 (2024) |
| Allergan, Inc. | $677.58 | 34 | $0 (2022) |
| Amgen Inc. | $604.55 | 35 | $0 (2023) |
| PFIZER INC. | $538.47 | 53 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $507.29 | 19 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,720 | 53 | Corcept Therapeutics ($296.51) |
| 2023 | $1,832 | 60 | AstraZeneca Pharmaceuticals LP ($435.19) |
| 2022 | $1,804 | 67 | Merz North America, Inc. ($471.08) |
| 2021 | $1,134 | 68 | GlaxoSmithKline, LLC. ($142.79) |
| 2020 | $759.75 | 30 | MERZ NORTH AMERICA, INC. ($163.18) |
| 2019 | $2,151 | 123 | Lilly USA, LLC ($229.53) |
| 2018 | $1,715 | 80 | Allergan Inc. ($430.13) |
| 2017 | $2,372 | 144 | Boehringer Ingelheim Pharmaceuticals, Inc. ($397.56) |
All Payment Transactions
625 individual payment records from CMS Open Payments — Page 1 of 25
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | ShockWave Medical, Inc | Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter (Device) | Food and Beverage | In-kind items and services | $148.38 | General |
| Category: Lithoplasty | ||||||
| 12/11/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $14.11 | General |
| Category: RESPIRATORY | ||||||
| 12/11/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $4.28 | General |
| Category: Diabetes | ||||||
| 11/21/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $17.33 | General |
| Category: Endocrinology | ||||||
| 11/12/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $6.45 | General |
| Category: Diabetes | ||||||
| 10/24/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $114.99 | General |
| Category: DIABETES | ||||||
| 10/15/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $16.13 | General |
| Category: Obesity | ||||||
| 10/07/2024 | Corcept Therapeutics | Korlym (Drug) | Education | In-kind items and services | $11.29 | General |
| Category: Endocrinology | ||||||
| 10/06/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $13.44 | General |
| Category: Endocrinology | ||||||
| 09/26/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.81 | General |
| Category: RESPIRATORY | ||||||
| 09/23/2024 | Corcept Therapeutics | Korlym (Drug) | Education | In-kind items and services | $11.29 | General |
| Category: Endocrinology | ||||||
| 09/19/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $13.05 | General |
| Category: DIABETES | ||||||
| 09/12/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $102.30 | General |
| Category: Endocrinology | ||||||
| 09/09/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $15.27 | General |
| Category: PAIN | ||||||
| 09/04/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $4.04 | General |
| Category: Diabetes | ||||||
| 08/21/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $14.01 | General |
| Category: Diabetes | ||||||
| 08/12/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.35 | General |
| Category: Diabetes | ||||||
| 08/05/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $15.22 | General |
| Category: Neuromodulation | ||||||
| 07/30/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Food and Beverage | Cash or cash equivalent | $116.15 | General |
| Category: Obesity | ||||||
| 07/30/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $12.54 | General |
| Category: DIABETES | ||||||
| 07/24/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $25.35 | General |
| Category: VACCINES | ||||||
| 07/24/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $17.03 | General |
| Category: Endocrinology | ||||||
| 07/17/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $13.27 | General |
| Category: FACIAL AESTHETICS | ||||||
| 06/27/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $7.78 | General |
| Category: Diabetes | ||||||
| 06/25/2024 | SRS Medical Systems, Inc. | CT3000 Pro Base Unit (Device), UroCuff-DC Disposable, Single | Food and Beverage | Cash or cash equivalent | $24.04 | General |
| Category: Urology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 974 | 1,339 | $197,958 | $77,638 |
| 2022 | 18 | 975 | 1,346 | $198,513 | $80,554 |
| 2021 | 13 | 738 | 1,014 | $99,190 | $62,920 |
| 2020 | 18 | 683 | 991 | $116,376 | $54,541 |
All Medicare Procedures & Services
63 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 120 | 316 | $82,267 | $27,071 | 32.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 137 | 137 | $36,230 | $16,930 | 46.7% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 135 | 135 | $22,576 | $10,606 | 47.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 104 | 144 | $26,542 | $9,333 | 35.2% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 49 | 49 | $7,027 | $3,518 | 50.1% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 136 | 136 | $5,219 | $2,392 | 45.8% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 121 | 121 | $4,643 | $2,128 | 45.8% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2023 | 30 | 34 | $3,792 | $1,823 | 48.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 50 | 50 | $3,154 | $1,477 | 46.8% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 16 | 109 | $3,160 | $1,132 | 35.8% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 24 | 35 | $1,693 | $510.40 | 30.1% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 16 | 16 | $1,009 | $472.16 | 46.8% |
| 81002 | Urinalysis, manual test | Office | 2023 | 25 | 46 | $320.16 | $156.86 | 49.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 11 | 11 | $325.32 | $87.84 | 27.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 124 | 329 | $78,085 | $27,492 | 35.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 105 | 105 | $28,111 | $13,202 | 47.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 116 | 172 | $29,624 | $10,877 | 36.7% |
| 99497 | Advance care planning, first 30 minutes | Office | 2022 | 126 | 126 | $21,515 | $10,149 | 47.2% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 12 | 12 | $6,809 | $3,337 | 49.0% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2022 | 20 | 20 | $6,848 | $3,234 | 47.2% |
| G0442 | Annual alcohol misuse screening, 15 minutes | Office | 2022 | 123 | 123 | $4,805 | $2,214 | 46.1% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 30 | 30 | $3,916 | $2,056 | 52.5% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 100 | 100 | $3,830 | $1,766 | 46.1% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2022 | 33 | 42 | $3,580 | $1,277 | 35.7% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2022 | 24 | 26 | $2,225 | $1,148 | 51.6% |
About Dr. Pompeyo Chavez, MD
Dr. Pompeyo Chavez, MD is a Family Medicine healthcare provider based in Bastrop, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/14/2007. The National Provider Identifier (NPI) number assigned to this provider is 1821292426.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Pompeyo Chavez, MD has received a total of $13,487 in payments from pharmaceutical and medical device companies, with $1,720 received in 2024. These payments were reported across 625 transactions from 57 companies. The most common payment nature is "Food and Beverage" ($13,341).
As a Medicare-enrolled provider, Chavez has provided services to 3,370 Medicare beneficiaries, totaling 4,690 services with total Medicare billing of $275,652. Data is available for 4 years (2020–2023), covering 63 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Bastrop, TX
- Active Since 06/14/2007
- Last Updated 07/12/2010
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1821292426
Products in Payments
- JARDIANCE (Drug) $1,307
- FARXIGA (Drug) $592.28
- Vascepa (Drug) $496.24
- TRELEGY ELLIPTA (Drug) $441.22
- PROCLAIM (Device) $373.84
- Ozempic (Drug) $369.03
- ENTRESTO (Drug) $336.93
- Rybelsus (Drug) $300.24
- Korlym (Drug) $296.51
- BREZTRI (Drug) $293.28
- XARELTO (Drug) $291.09
- Xeomin (Biological) $269.49
- Tresiba (Drug) $251.85
- MOUNJARO (Drug) $238.50
- Impella (Device) $229.42
- Repatha (Biological) $220.80
- INVOKANA (Drug) $216.20
- SHOCKWAVE IVL SYSTEM WITH THE SHOCKWAVE C2 CORONARY IVL CATHETER (Device) $192.62
- ELIQUIS (Drug) $188.66
- Aimovig (Biological) $166.58
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Bastrop
Tahir Qayyum, Md, MD
Family Medicine — Payments: $19,802
Dr. Laurier Vocal, Md, MD
Family Medicine — Payments: $12,679
Allen Jarzombek, Md, MD
Family Medicine — Payments: $7,725
Dr. Desmar Walkes, M.d, M.D
Family Medicine — Payments: $3,914
James Smith, M.d, M.D
Family Medicine — Payments: $2,562
Sammy Lerma, M.d, M.D
Family Medicine — Payments: $2,498